CoreValve Evolut
Device Transcatheter Valve Systems
PDI 00643169565623
General payments
$5,113,578
Research payments
$9,595,250
Through program year 2021, $5,113,578 in general payments and $9,595,250 in research payments were reported against CoreValve Evolut (Transcatheter Valve Systems).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $5,113,578 | 19,486 |
| 2021 | Research | $9,595,250 | 1,984 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 88 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
19,486 general · 1,984 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.